| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10909111 | Leukemia Research | 2012 | 8 Pages |
Abstract
The preclinical results and responses of patients on a clinical trial warrant further investigation of ON 01910.Na as a potential novel targeted therapy for higher risk MDS patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Matthew J. Olnes, Aarthie Shenoy, Barbara Weinstein, Loretta Pfannes, Kelsey Loeliger, Zachary Tucker, Xin Tian, Minjung Kwak, Francois Wilhelm, Agnes S.M. Yong, Irina Maric, Manoj Maniar, Phillip Scheinberg, Jerome Groopman, Neal S. Young,